Fine Chemicals

Peter Pollak, PhD, is a consultant for the fine chemicals industry. He worked for Lonza in Switzerland and the United States for more than thirty years, in positions including senior vice president and general manager of fine chemicals. He is internationally recognized as a pioneer in the development of the modern pharmaceutical fine chemicals industry.

ACKNOWLEDGMENTS. PREFACE. PART I THE INDUSTRY. 1. What Fine Chemicals Are. 1.1 Defi nition. 1.2 Positioning on the Value-Added Chain. 2. The Fine-Chemical Industry. 2.1 Fine-Chemical/Custom Manufacturing Companies. 2.2 Contract Research Organizations. 2.3 Laboratory Chemical Suppliers. 3. Products. 3.1 Small Molecules. 3.2 Big Molecules. 4. Technologies. 4.1 Traditional Chemical Synthesis. 4.2 Biotechnology. 5. Facilities and Plants. 5.1 Plant Design. 5.2 Plant Operation. 6. Research and Development. 6.1 Objectives. 6.2 Project Initiation. 6.3 Project Execution and Management. 7. Cost Calculation. 7.1 Investment Cost. 7.2 Manufacturing Costs. 8. Management Aspects. 8.1 Risk/Reward Profi le. 8.2 Performance Metrics and Benchmarking. 8.3 Organization. Bibliography. PART II THE BUSINESS. 9. Market Size and Structure. 9.1 Fine-Chemical Market Size. 9.2 Market Breakdown by Major Applications. 10. The Business Condition. 10.1 Offer. 10.2 Demand. 11. Customer Base. 11.1 Pharmaceutical Industry. 11.2 Agrochemical Industry. 11.3 Animal Health Industry. 11.4 Other Specialty-Chemical Industries. 12. Marketing. 12.1 Organization and Tasks. 12.2 Target Products and Services. 12.2.1 Exclusives: Custom Manufacturing. 12.2.2 Nonexclusives: API-for-Generics. 12.2.3 Standard Products. 12.3 Target Markets: Geographic Regions and Customer Categories. 12.4 Distribution Channels. 12.5 Pricing. 12.6 Intellectual Property Rights. 12.7 Supply Contracts. 12.8 Promotion. 12.9 Network and Contact Development. 12.10 Key Account Management and Collaborative Relationship. Bibliography. PART III OUTLOOK. 13. General Trends and Growth Drivers. 14. Globalization. 15. Biotechnology. 15.1 Small Molecules. 15.2 Big Molecules (Biopharmaceuticals). 16. Ethical Pharmaceutical Industry/Custom Manufacturing. 16.1 Restructuring and Outsourcing. 16.2 R&D Productivity. 17. Generics Industry/API-for-Generics. 18. Agro Fine Chemicals. 19. Contract Research Organizations. 20. Conclusion: Who Is Fittest for the Future? Bibliography. ABBREVIATIONS. APPENDIX. A.1 Information Sources/Life Sciences. A.2 Checklist for New Product Evaluation. A.3 Product Schedule, Custom Manufacturing Product. A.4 Company Scorecard. A.5 Job Description for Business Development Manager. A.6 Selection Criteria for Outsourcing Partners. A.7 Checklist for Customer Visit. A.8 Outline for a Company Presentation. A.9 Overseas Expansion of Indian Fine-Chemical Companies. INDEX.